Eureka Alert

Three new honorary doctors have been appointed by the Swedish medical university Karolinska Institutet. Paolo Chiesi, Douglas Easton, and Sophie Ekman will have their doctorates formally conferred at Stockholm City Hall on 10 May 2019.

Paolo Chiesi has as part of the family company Chiesi Farmaceutici S.p.A. since 1987 supported research on surfactant. In the early 1980’s researchers at Karolinska Institutet developed a substance called Curosurf, intended on treating prematurely born children suffering from respiratory distress syndrome. Curosurf is derived from the lungs of pigs, and a collaboration with the pharmaceutical industry became necessary in order to produce a sufficient quantity. As head of research at Chiesi Farmaceutici, Paolo Chiesi supported the project from the start.

Beyond financial support, Paolo Chiesi also launched Curosurf on the market and has continued to support annual international research meetings for neonatologists. With the support of Chiesi Farmaceutici, a synthetic version of surfactant has now been developed at Karolinska Institutet, and is currently undergoing clinical tests. If successful, synthetic surfactant could lead to more premature born children being treated.

“I feel honored to receive this honorary degree from one of the most prestigious and respected medical universities of the world. I am grateful,


Article originally posted at

Click here for the full story


Privacy Policy / Terms Of Use

       Powered by MMD